RSEBX | RSLAX | RSEBX / RSLAX | |
Total Expense Ratio | 1.45 | 1.74 | 83% |
Annual Report Gross Expense Ratio | 1.45 | 1.74 | 83% |
Fund Existence | 11 years | 23 years | - |
Gain YTD | 9.389 | 9.178 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 80.3B | 80.3B | 100% |
Annual Yield % from dividends | 0.23 | 0.11 | 215% |
Returns for 1 year | 9.79 | 9.47 | 103% |
Returns for 3 years | 20.18 | 19.14 | 105% |
Returns for 5 years | 12.50 | 9.35 | 134% |
Returns for 10 years | 44.85 | 35.72 | 126% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 67.81 | 0.63 | +0.93% |
Invesco Biotechnology & Genome ETF | |||
SZOXF | 7.01 | N/A | N/A |
Deutsche Bank AG (London Branch) | |||
TDTF | 24.14 | -0.03 | -0.12% |
FlexShares iBoxx 5Yr Target Dur TIPS ETF | |||
ITOT | 140.57 | -0.33 | -0.23% |
iShares Core S&P Total US Stock Mkt ETF | |||
KNGZ | 34.61 | -0.11 | -0.32% |
FirstTrust S&P500 DvrsDiv AristocratsETF |